Experimental Drug Shows Promise in Lowering Cholesterol, Heart Attack Risk
Adding the ‘investigational biologic’ evolocumab to statin therapy works better, study saysContinue Reading
Adding the ‘investigational biologic’ evolocumab to statin therapy works better, study saysContinue Reading
CT may slightly outperform ‘functional’ tests because it helps rule out unnecessary procedures, researchers sayContinue Reading
Company-funded trial finds lower rates of heart attack, death with Brilinta versus placeboContinue Reading
People with hypertrophic cardiomyopathy are benefiting from defibrillators, other advancesContinue Reading
Study found damage to organs and tissues, even with no sign of hypertensionContinue Reading
Transcatheter procedure was designed for patients too frail for open heart surgeryContinue Reading
Poorer cardiac function linked to doubled odds for mental declineContinue Reading
May help more people survive cardiac arrest, FDA says
Continue Reading
Three small handfuls a week lowered risk factors in study, but few kids eat enoughContinue Reading
Three small handfuls a week lowered risk factors in study, but few kids eat enoughContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.